Technological advancements have a profound impact on cancer research and treatment. The use of next-generation sequencing allows for comprehensive analysis of cancer genomes, facilitating the identification of specific mutations that can be targeted by new drugs. CRISPR-based gene editing technologies offer the potential to correct genetic defects at their source. Additionally, the development of advanced imaging techniques enables earlier detection and more precise monitoring of tumors.
